GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment.
GSK2556286 是一种新型抗结核药物候选物,在体内有效,有可能缩短结核病疗程
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00132-22
Nuermberger Eric L, MartÃnez-MartÃnez Maria Santos, Sanz Olalla, Urones Beatriz, Esquivias Jorge, Soni Heena, Tasneen Rokeya, Tyagi Sandeep, Li Si-Yang, Converse Paul J, Boshoff Helena I, Robertson Gregory T, Besra Gurdyal S, Abrahams Katherine A, Upton Anna M, Mdluli Khisimuzi, Boyle Gary W, Turner Sam, Fotouhi Nader, Cammack Nicholas C, Siles Juan Miguel, Alonso Marta, Escribano Jaime, Lelievre Joel, Rullas-Trincado Joaquin, Pérez-Herrán Esther, Bates Robert H, Maher-Edwards Gareth, Barros David, Ballell LluÃs, Jiménez Elena